Bellevue Group’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.03M | Sell |
85,438
-5,753
| -6% | -$204K | 0.07% | 89 |
|
2025
Q1 | $3.09M | Sell |
91,191
-76,150
| -46% | -$2.58M | 0.07% | 95 |
|
2024
Q4 | $5.45M | Sell |
167,341
-1,793
| -1% | -$58.3K | 0.1% | 94 |
|
2024
Q3 | $8.24M | Sell |
169,134
-200,136
| -54% | -$9.75M | 0.13% | 91 |
|
2024
Q2 | $16.4M | Buy |
369,270
+76,000
| +26% | +$3.37M | 0.27% | 84 |
|
2024
Q1 | $16.4M | Buy |
293,270
+91,516
| +45% | +$5.13M | 0.25% | 83 |
|
2023
Q4 | $12.1M | Sell |
201,754
-76,400
| -27% | -$4.6M | 0.19% | 84 |
|
2023
Q3 | $18.7M | Buy |
278,154
+2,400
| +0.9% | +$161K | 0.3% | 75 |
|
2023
Q2 | $19M | Sell |
275,754
-231,500
| -46% | -$16M | 0.27% | 81 |
|
2023
Q1 | $24.5M | Buy |
507,254
+152,465
| +43% | +$7.35M | 0.35% | 71 |
|
2022
Q4 | $17.7M | Sell |
354,789
-270,672
| -43% | -$13.5M | 0.24% | 89 |
|
2022
Q3 | $25.5M | Sell |
625,461
-4,978
| -0.8% | -$203K | 0.37% | 72 |
|
2022
Q2 | $34.7M | Sell |
630,439
-29,630
| -4% | -$1.63M | 0.49% | 59 |
|
2022
Q1 | $24M | Buy |
660,069
+2,413
| +0.4% | +$87.7K | 0.28% | 89 |
|
2021
Q4 | $30.7M | Buy |
657,656
+371,100
| +130% | +$17.3M | 0.32% | 86 |
|
2021
Q3 | $14.5M | Sell |
286,556
-103,607
| -27% | -$5.24M | 0.15% | 105 |
|
2021
Q2 | $16M | Sell |
390,163
-213,080
| -35% | -$8.75M | 0.16% | 113 |
|
2021
Q1 | $17.5M | Buy |
603,243
+186,902
| +45% | +$5.42M | 0.19% | 103 |
|
2020
Q4 | $11.7M | Buy |
+416,341
| New | +$11.7M | 0.13% | 113 |
|
2020
Q3 | – | Sell |
-134,261
| Closed | -$5.71M | – | 219 |
|
2020
Q2 | $5.71M | Buy |
+134,261
| New | +$5.71M | 0.08% | 122 |
|